SAN JOSE, Calif. — Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc. (“Takara Bio”), today announced that Carol Lou will retire as President and Chief Executive Officer of Takara Bio USA on July 10 after more than two decades with the company. Andrew Farmer, D.Phil., who has served as Chief Scientific […]
New leaders bring extensive leadership experience across life sciences, diagnostics, and medical technology SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Mike Sullivan as Chief Commercial Officer, effective July 20, 2026, and Julie Coletti as Chief Legal Officer, effective August 3, 2026. The appointments add experienced leaders to Illumina’s Executive Leadership […]
New magnetic bead-based workflow isolates genomic DNA up to 450 kb while supporting both manual and automated sample preparation We developed the HMW DNA Kit to help researchers recover ultra-high molecular weight DNA through a streamlined, automation-ready process that delivers reliable results across multiple sample types.” — Julie Baggs, Scientific Director ATLANTA, GA, UNITED STATES […]
IPSWICH, Mass. — New England Biolabs (NEB®) has launched the NEBNext Companion Module for Oxford Nanopore Technologies Direct RNA Sequencing. The companion module contains the NEB reagents recommended by Oxford Nanopore for execution of the Direct RNA Sequencing workflow (RNA004 sequencing kit), providing a simple and convenient format for scientists performing a wide range of […]
Partnership with Hamburg Trading Corp to advance applied testing and life science research Serving as a learning hub to empower the next generation of Filipino scientists through hands-on access to molecular workflows Facility designed to remove logistical barriers for researchers, enabling on-site evaluation without the need for internal equipment clearances Singapore, Singapore – QIAGEN, a […]
No Stockholder Action Required at This Time REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it has received an unsolicited, non-binding proposal from Omid Farokhzad, M.D., Seer’s Chair and Chief Executive Officer, to acquire all of the outstanding shares of Seer’s Class […]
Agreement Part of Arima’s Long-Term Strategy to Focus on Core Diagnostic Platform and Tests CARLSBAD, Calif. — Arima Genomics, Inc., a cancer diagnostics company bringing DNA sequence and structure together to advance cancer therapy selection, today announced a distribution partnership with Active Motif Incorporated, a leading provider of epigenetics and multiomic solutions to mechanistic, translational, and […]
Seer’s particle-based proteomics IP withstands challenges in both Europe and the United States REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for deep, unbiased proteomic insights, today announced two significant developments that reinforce the strength of the intellectual property portfolio protecting its proprietary nanoparticle protein enrichment technology. These milestones underscore Seer’s […]
Accelerating Entry into the Middle East Energy Transition Market HORIBA, Ltd. (President: Masayuki Adachi; hereinafter “HORIBA”) announced on February 13, 2026, the establishment of HORIBA Middle East Limited in Abu Dhabi. The new company marks HORIBA’s first presence in the Middle East and will be located in Masdar City, a pioneering sustainable urban community and […]
Joint offering creates state-of-the-art workflow uniting Promega’s fast and reliable nucleic acid extraction instrumentation with Countable Labs’ accurate and easy-to-use Countable PCR technology to deliver accuracy across research PALO ALTO, Calif. & MADISON, Wis. — Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures biology, announced a co-marketing agreement […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
